Cybin Inc. Common Stock
HELP
Rank in Stocks
#11772
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Share Price
$6.89
Last synced: 2026-11-18
Market Cap
$503.43M
Change (1 day)
-4.31%
Change (1 year)
-
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cybin Inc. Common Stock (HELP)
Category
Healthcare
P/S ratio for Cybin Inc. Common Stock (HELP)
P/S ratio as of November 2026 TTM: 0.00
According to Cybin Inc. Common Stock's latest financial reports and stock price, its current price-to-sales ratio (TTM) is 0.00. At the end of 2025 the company had a P/S ratio of 0.00.
P/S ratio history for Cybin Inc. Common Stock from 2017 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | -100.00% |
| 2021 | 5.94K | 0.00% |
| 2020 | 0.00 | 0.00% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 10.51 | - |
US
|
|
| 35.79 | - |
US
|
|
| 4.19 | - |
AU
|
|
| 6.63 | - |
BE
|
|
| 13.60 | - |
NL
|
Questions about Cybin Inc. Common Stock's P/S ratio
What was Cybin Inc. Common Stock's P/S ratio in 2025?
In 2025, Cybin Inc. Common Stock's P/S ratio was 0.00, compared with 0.00 in 2024.
How has Cybin Inc. Common Stock's P/S ratio changed since 2020?
From 2020 to 2025, Cybin Inc. Common Stock's P/S ratio was highest in 2021 (5.94K) and lowest in 2025 (0.00).
How does Cybin Inc. Common Stock's P/S ratio compare with similar companies?
Cybin Inc. Common Stock's P/S ratio (0.00) is lower than that of all 5 similar companies listed above. The highest among them is Moderna, Inc., with 35.79.